Published on

Toxicology – Tin


Core Concept

“Tin poisoning” is not a single toxic syndrome. Toxicity depends heavily on the chemical form of tin.

The clinically useful division is:

Metallic/inorganic tin → generally low systemic toxicity, with GI irritation or chronic pulmonary deposition depending on the compound and route

Reactive/corrosive tin compounds → local chemical burns and respiratory irritation

Organotin compounds → substantially greater systemic toxicity, especially neurotoxicity

This distinction is more useful than treating every tin exposure as heavy-metal poisoning.

Current NIOSH guidance reflects this difference: the occupational limit for metallic/inorganic tin is 2 mg/m³, whereas organic tin compounds have a much lower limit of 0.1 mg/m³, reflecting their greater toxicity.


Forms and Uses

Metallic tin is used in tin plating, solder, alloys such as bronze, electronics, ceramics, and industrial manufacturing.

Tin compounds are used as catalysts, stabilizers, coatings, and chemical intermediates.

Stannous fluoride remains a legitimate modern anticaries ingredient in toothpastes and other dental products; FDA’s current OTC monograph permits stannous fluoride in dentifrices at defined concentrations.

Organotin compounds contain one or more carbon–tin bonds. Important historical and industrial examples include:

Trimethyltin

Dimethyltin

Triethyltin

Tributyltin

Triphenyltin

and related mono-, di-, tri-, and tetraorganotin compounds.

Organotins have been used in PVC stabilization, industrial catalysis, pesticides, fungicides, and historically marine antifouling paints.


Organotin Toxicity Is Compound-Specific

The term “organotin” covers chemically and toxicologically diverse compounds.

In general:

Trialkyltins such as trimethyltin and triethyltin are particularly neurotoxic.

Other organotins may produce prominent skin, eye, respiratory, hepatic, renal, or gastrointestinal toxicity.

NIOSH lists organic tin exposure as occurring through inhalation, ingestion, skin absorption, and skin/eye contact, with potential neurologic disturbances, paresis, focal sensory abnormalities, GI symptoms, respiratory irritation, and skin burns.

Therefore:

Always identify the exact tin compound before predicting toxicity.


Toxic Dose

There is no useful universal toxic dose for “tin.”

Metallic tin and many inorganic tin compounds have relatively low oral systemic toxicity and generally require substantial or repeated exposure for clinically important systemic effects.

However, even inorganic compounds can produce gastrointestinal irritation. Human data reviewed by EFSA found GI irritation after a bolus equivalent to approximately 40 mg elemental tin from stannous chloride, illustrating that “inorganic tin is nontoxic” is too broad.

Organotins can be far more toxic, but precise human toxic-dose thresholds are not established.

Thus:

There is no single milligram-per-kilogram toxic dose applicable across tin compounds.


Pathophysiology – Metallic and Inorganic Tin

Metallic tin is relatively insoluble and poorly absorbed from the gastrointestinal tract.

Many inorganic tin compounds are also absorbed inefficiently and primarily cause local gastrointestinal irritation rather than severe systemic metal toxicity.

The older statement that all noncaustic inorganic tin compounds are “not toxic when ingested” should therefore be softened to:

Most metallic and noncorrosive inorganic tin exposures have low systemic toxicity, but sufficiently large soluble exposures can cause GI and systemic effects.


Corrosive Tin Compounds

Certain tin compounds are much more locally hazardous.

Tin(IV) chloride (stannic chloride; SnCl₄) is a fuming liquid with an acrid odor and can produce marked mucosal and respiratory irritation. NIOSH classifies stannic chloride among inorganic tin compounds and describes its fuming physical properties.

Concentrated reactive tin halides can therefore behave primarily as chemical corrosives, rather than as systemic heavy-metal poisons.

The important sequence is:

Reactive tin compound → local chemical reaction with moist tissue → mucosal injury → airway/GI burns


Pathophysiology – Organotins

Organotin toxicity is more complex.

Lipophilic alkyl tin compounds can penetrate biologic membranes and interfere with:

Mitochondrial energy metabolism

Membrane function

Ion homeostasis

Myelin integrity

Neuronal signaling

Several organotins also interfere with endocrine and transcriptional pathways.

For trimethyltin, the central nervous system is the major target.

A useful toxicologic sequence is:

Trimethyltin exposure → neuronal/white-matter toxicity → limbic + cerebellar dysfunction → amnesia + behavioral disturbance + ataxia + seizures ± persistent neurologic disability


Trimethyltin Neurotoxicity

Trimethyltin is one of the best-characterized severe human organotin toxicants.

A classic occupational cluster of six workers exposed by inhalation developed:

Hearing loss, disorientation, confabulation, amnesia, aggression, behavioral change, seizures, nystagmus, ataxia, and sensory neuropathy.

One patient died and two were left severely disabled.

This is substantially more serious than the older general description of organotin toxicity might suggest.


Delayed Neurologic Toxicity

Organotin neurotoxicity may not be immediate.

A well-documented trimethyltin exposure produced delirium, spatial disorientation, perseveration, inappropriate affect, and memory impairment approximately 72 hours after exposure, followed by persistent seizures and neuropsychological abnormalities years later.

Therefore:

A normal examination immediately after major trimethyltin exposure does not exclude evolving encephalopathy.


Modern Human Organotin Series

A clinical series of 15 occupational organotin poisonings found frequent:

Hypokalemia

Metabolic acidosis

Hyperammonemia

Hepatic enzyme elevation

and, in severe cases:

CNS demyelinating abnormalities on CT/MRI + respiratory failure requiring ventilation.

Fourteen of 15 patients ultimately recovered, although severe cases required prolonged treatment.

Thus significant organotin toxicity should be approached as a potential multisystem neuro-metabolic poisoning, not simply a local irritant exposure.


Leukoencephalopathy

Modern reports continue to document organotin-associated white-matter injury.

Workers exposed to dimethyltin and trimethyltin have developed amnesia with symmetric abnormalities of the periventricular white matter and corpus callosum on MRI.

A more recent case of occupational organotin toxicity demonstrated diffuse bilateral white-matter lesions together with markedly elevated blood and urine tin concentrations.

MRI should therefore be considered when significant exposure produces:

Persistent memory impairment, ataxia, encephalopathy, seizures, or focal neurologic abnormalities.


Hearing Loss

Hearing impairment is a recognized feature of severe trimethyltin neurotoxicity.

In the classic six-worker cluster, hearing loss accompanied limbic and cerebellar dysfunction.

Thus tinnitus or hearing loss after occupational organotin exposure can be an important clue to the diagnosis.


Behavioral and Cognitive Effects

Organotin encephalopathy can produce striking psychiatric manifestations, including:

Agitation, aggression, disinhibition, delirium, apathy, confusion, amnesia, confabulation, and psychomotor slowing.

These symptoms may be mistaken for psychiatric disease, alcohol/drug intoxication, or metabolic encephalopathy.

A known workplace involving PVC processing, organotin catalysts, or tin-containing scrap should increase suspicion.


Cerebellar Toxicity

Ataxia, tremor, nystagmus, and impaired coordination are characteristic manifestations of severe trimethyltin poisoning.

The combination:

Memory disturbance + behavioral change + ataxia

is particularly suggestive of trimethyltin neurotoxicity in an appropriate occupational setting.


Seizures

Seizures can occur in severe organotin encephalopathy.

They may be generalized or focal and can persist well beyond the acute exposure. In one documented trimethyltin case, complex partial seizures persisted for years.

Treat seizures with benzodiazepines first-line, followed by standard toxicologic status-epilepticus management if needed.


Peripheral Neuropathy

Peripheral sensory and motor abnormalities can occur, although they are generally less characteristic than the encephalopathic and cerebellar manifestations of trimethyltin.

Recovery from significant neurologic injury can require months, and permanent deficits have been documented.


Hypokalemia

Severe hypokalemia has repeatedly been described in human organotin poisoning.

One trimethyltin case developed potassium of approximately 2.1 mmol/L in association with diffuse toxic leukoencephalopathy.

The 15-patient organotin series likewise found hypokalemia in all cases studied.

Therefore:

Check potassium repeatedly in significant organotin exposure.

Replacement may need to be substantial, but should remain laboratory-guided.


Metabolic Acidosis

Metabolic acidosis has also been reported commonly in significant organotin poisoning.

It may reflect combined cellular toxicity, respiratory compromise, seizures, or systemic illness.

Severe acidosis warrants evaluation for:

  • Shock
  • Seizure
  • Respiratory failure
  • Renal dysfunction
  • Coexposures

Correct the underlying cause rather than giving bicarbonate automatically for every mild laboratory abnormality.


Hyperammonemia

The 15-patient occupational series found elevated ammonia concentrations in many patients with organotin poisoning.

This is not sufficiently specific to diagnose organotin toxicity, but ammonia can be useful when unexplained encephalopathy accompanies a compatible industrial exposure.


Hepatic Toxicity

Organotin exposure can produce hepatic injury.

NIOSH lists hepatic necrosis among animal toxicities for organic tin compounds, while human occupational series have demonstrated elevated transaminases.

Monitor liver function after substantial systemic exposure.


Renal Toxicity

Renal injury is possible after significant organotin exposure, although the CNS is often the dominant target in trialkyltin poisoning.

Renal function should be monitored in symptomatic patients, especially in those with:

  • Hypotension
  • Rhabdomyolysis
  • Severe metabolic disturbances
  • Multiorgan toxicity


Gastrointestinal Effects

Tin-containing exposures may cause:

Nausea + vomiting + abdominal pain + diarrhea

after either soluble inorganic tin or organotin ingestion.

Organotin compounds may also be directly irritant or corrosive depending on their chemical structure and concentration. NIOSH lists abdominal pain, vomiting, and skin burns among organic-tin effects.


Caustic Gastrointestinal Injury

When the specific tin product is strongly corrosive, management should follow modern caustic-ingestion principles.

Potential manifestations include:

Odynophagia, drooling, dysphagia, chest or abdominal pain, hematemesis, vomiting, and perforation.

The absence of visible oral burns does not reliably exclude deeper esophageal or gastric injury.


Pulmonary Effects – Acute Exposure

Acute inhalation of irritating tin compounds or organotin vapors can produce:

Cough, sore throat, dyspnea, wheezing, and respiratory irritation.

NIOSH recognizes the respiratory system as a target of organic tin compounds.

Severe exposure may require oxygen, bronchodilators, serial respiratory assessment, imaging, and occasionally mechanical ventilation.


Stannosis

Long-term inhalation of tin oxide dust or fume can produce:

Stannosis

Stannosis is a nonfibrotic pneumoconiosis caused by deposition of tin oxide particles within the lungs. Modern radiologic reviews classify stannosis alongside siderosis and baritosis as nonfibrotic pneumoconioses.

NIOSH lists stannosis as the characteristic occupational effect of both tin(II) oxide and tin(IV) oxide exposure.


Is Stannosis Truly “Benign”?

Historically, stannosis was called benign pneumoconiosis because dramatic chest-radiograph abnormalities could occur without progressive massive fibrosis or major physiologic impairment.

That historical description remains broadly useful, but it should not be interpreted as meaning that chronic tin-oxide inhalation is harmless.

NIOSH recognizes dyspnea and decreased pulmonary function as potential manifestations of tin-oxide exposure.

Therefore:

Stannosis is generally nonfibrotic, but occupational exposure still warrants prevention and pulmonary evaluation.


Metal Fume Fever – Important Nuance

Older texts sometimes group tin fumes broadly with “metal fume fever.”

Modern literature shows that classic metal fume fever is most strongly associated with zinc oxide and related welding exposures.

Tin oxide exposure is much better established as a cause of stannosis than as a classic cause of metal fume fever.

Therefore:

Do not automatically diagnose metal fume fever simply because tin-containing welding or soldering was involved.

Evaluate for other metals, especially zinc, as well as flux decomposition products and other inhaled irritants.


Dermal Exposure

Organic tin compounds can be absorbed through skin.

NIOSH assigns organic tin compounds a skin notation and recognizes skin absorption as a significant exposure route.

Dermal exposure may produce:

  • Irritation
  • Chemical burns
  • Pruritus
  • Systemic toxicity after substantial exposure

Prompt removal of contaminated clothing and thorough washing are important.


Ocular Exposure

Tin compounds can cause eye irritation or chemical injury.

Immediately irrigate exposed eyes with copious water or saline and continue until contamination has been thoroughly removed.

Persistent pain, corneal abnormality, or visual change requires ophthalmologic assessment.


Diagnosis

Diagnosis begins by identifying the exact tin compound and route of exposure.

Ask specifically:

  • Metallic versus inorganic versus organotin?
  • Exact product label/SDS?
  • Oral, dermal, ocular, or inhalational?
  • Workplace process?
  • PVC manufacturing or plastics?
  • Pesticide/antifouling product?
  • Heated tin or solder?
  • Coexposure to lead, zinc, cadmium, solvents, acids, or flux fumes?

Without compound identification, “tin level elevated” may be clinically difficult to interpret.


Blood and Urine Tin Testing

Blood and urine tin concentrations can support the diagnosis after significant exposure, particularly when specialized laboratories perform organotin speciation.

Human cases of occupational organotin encephalopathy have demonstrated high urinary concentrations of dimethyltin and trimethyltin, with concentrations falling after exposure ceased.

A recent severe case also demonstrated markedly elevated blood and urine tin with compatible leukoencephalopathy.

However:

There is no universally validated blood or urine tin concentration that predicts clinical severity or mandates treatment.


The Old “Normal Urinary Tin” Cutoff Is Not Reliable

The older chapter quotes a “normal urine level” of 16.6 μg/L or 23.4 μg/day.

These should not be used as universal modern reference values.

Reference ranges vary by:

  • Analytical method
  • Total tin versus organotin speciation
  • Occupational background
  • Timing after exposure
  • Sample contamination

Interpretation should therefore be performed with an occupational/environmental toxicologist and the testing laboratory.


Organotin Speciation

This is particularly important because:

Total tin does not tell you which tin species caused the exposure.

A modest total-tin concentration from an inorganic source is not toxicologically equivalent to exposure to neurotoxic trimethyltin.

Whenever clinically available, compound-specific or organotin-speciation testing is more informative than total tin alone.


Neurologic Investigations

For clinically important organotin neurotoxicity consider:

MRI brain

EEG if seizures or persistent encephalopathy occur

Formal neuropsychological testing during recovery

MRI can demonstrate white-matter, corpus-callosum, brainstem, or cerebellar abnormalities in severe organotin poisoning.


Other Laboratory Testing

In symptomatic systemic exposure obtain:

CBC, electrolytes, potassium, magnesium, glucose, bicarbonate, BUN/creatinine, liver enzymes, bilirubin, and urinalysis.

In significant organotin poisoning also consider:

  • Blood gas
  • Lactate
  • Ammonia
  • CK
  • ECG

Serial testing is more useful than a single initial panel when neurologic toxicity is evolving.


Respiratory Evaluation

For significant inhalational exposure assess:

Pulse oximetry + work of breathing + auscultation

and, when indicated:

Chest radiography or CT + blood gas

Patients with persistent symptoms or substantial exposure may require observation because pneumonitis can evolve after the initial encounter.


Initial Treatment

There is no universal tin-specific resuscitation algorithm.

Treatment begins with:

Stop exposure + ABC stabilization + identify the exact compound + supportive care

For substantial organotin exposure, early consultation with a poison center or medical toxicologist is appropriate.

Occupational exposures should also involve the workplace safety/SDS information whenever possible.


Dermal Decontamination

Remove contaminated clothing and jewelry.

Wash exposed skin thoroughly with soap and copious water.

Because organotin compounds can be absorbed through skin, decontamination should not be delayed. NIOSH specifically recognizes skin absorption for organic tin compounds.

Rescuers should wear suitable protective equipment when handling concentrated industrial products.


Inhalational Exposure

Immediately remove the patient from the contaminated atmosphere without exposing rescuers.

Provide supplemental oxygen when indicated.

Treat bronchospasm with standard inhaled bronchodilators.

Significant respiratory distress, hypoxemia, or evolving pulmonary injury warrants hospital monitoring.


Oral Exposure – Do Not Induce Vomiting

Do not use ipecac or otherwise induce emesis.

This is particularly important after corrosive tin compounds because vomiting re-exposes the esophagus and oropharynx.

Modern toxicology guidance has abandoned routine ipecac, and it is specifically contraindicated after corrosive ingestion.


Routine Dilution – Important Modern Correction

The old chapter advises up to 250 mL of water or milk after caustic tin ingestion, while simultaneously warning against dilution after tin chloride exposure.

That approach is too compound-specific and outdated for a general tin chapter.

Routine gastric dilution is not recommended after significant caustic ingestion.

Large oral fluid loads can provoke vomiting and aspiration and do not reliably prevent deep mucosal injury.

Management should instead prioritize airway assessment and expert caustic-injury evaluation.


Do Not Neutralize

Do not attempt to chemically neutralize a corrosive tin compound with an acid, base, or other reactive substance.

Neutralization can generate heat and worsen tissue injury.


Gastric Lavage

Do not perform routine gastric lavage after tin ingestion.

It is particularly inappropriate after corrosive compounds because tube placement and lavage may worsen mucosal injury, provoke vomiting, or cause perforation.

Modern caustic management specifically discourages gastric lavage.


Activated Charcoal – Caustic Tin Compounds

Activated charcoal should not be given for a primarily caustic tin ingestion.

It provides no meaningful treatment of tissue corrosion and can impair subsequent endoscopic visualization.

Contemporary emergency-toxicology guidance specifically lists significant caustic ingestion and metals among situations where activated charcoal is inappropriate or unlikely to help.


Activated Charcoal – Organotin Exposure

Routine charcoal is also not established treatment for organotin poisoning.

If a clearly noncorrosive, potentially life-threatening organotin product has been swallowed very recently, a toxicologist may occasionally consider single-dose charcoal when:

  • The compound is expected to be adsorbed
  • The airway is protected
  • There is no caustic injury

However, there is no good human evidence that charcoal improves organotin outcomes.

Thus:

Charcoal is selective—not routine—and should never be given simply because the poison contains tin.


Evaluation of Caustic Injury

When significant corrosive tin ingestion is suspected, modern evaluation follows general caustic-injury principles.

Airway compromise takes priority.

Assessment may include esophagogastroduodenoscopy (EGD) and/or contrast-enhanced CT depending on severity, local expertise, and patient characteristics.

A 2025 evidence-based gastroenterology guideline identifies EGD as the preferred initial assessment in many cases and reserves contrast CT for selected situations, while a very recent adult critical-care review emphasizes increasing use of contrast-enhanced CT in major caustic ingestion.

The exact strategy should therefore be individualized rather than based on an outdated fixed endoscopy rule.


Steroids After Caustic Injury

Do not routinely give corticosteroids solely to prevent esophageal stricture.

Evidence remains inconsistent and inadequate for indiscriminate prophylactic steroid therapy after caustic injury.

Steroids may be appropriate for another indication, but they are not a universal tin-ingestion treatment.


Antibiotics After Caustic Injury

Routine prophylactic antibiotics are not indicated solely because a caustic substance was swallowed.

Use antibiotics when there is:

  • Perforation
  • Infection
  • Aspiration pneumonia
  • Another established indication


Organotin Neurotoxicity – Supportive Treatment

For systemic organotin poisoning, treatment is principally:

Removal from exposure + neurologic monitoring + electrolyte correction + seizure treatment + respiratory support

Correct significant:

  • Hypokalemia
  • Acidemia
  • Dehydration
  • Metabolic disturbances

Mechanical ventilation may be required in severe cases; four patients in one occupational series required ventilatory support.


Seizure Treatment

Treat seizures with:

Benzodiazepines first-line

Refractory seizures should be treated according to standard toxicologic status-epilepticus protocols.

There is no tin-specific anticonvulsant.


Hypokalemia Treatment

Replace significant potassium deficits carefully with repeated monitoring.

Because severe organotin poisoning can produce persistent or refractory hypokalemia, replacement requirements may be substantial.

Continuous ECG monitoring is appropriate when hypokalemia is severe.


Metabolic Acidosis

Treat the cause.

Sodium bicarbonate may be considered for severe clinically important acidemia, but it is not an antidote to organotin compounds.

Correct:

  • Shock
  • Respiratory failure
  • Seizures
  • Severe electrolyte abnormalities

simultaneously.


Corticosteroids in Organotin Neurotoxicity

One published 15-patient series used high-dose methylprednisolone for severe organotin neurotoxicity and reported generally favorable outcomes.

However:

Corticosteroids are not an established antidote or evidence-based standard treatment for organotin poisoning.

The study was uncontrolled, and spontaneous recovery plus supportive treatment may account for much of the improvement.

Routine high-dose steroids should therefore not be extrapolated from this case series without specialist consultation.


Chelation

There is no established chelation regimen for tin or organotin poisoning.

Succimer has occasionally been used in human organotin poisoning. A recent patient with organotin-associated leukoencephalopathy improved after exposure cessation and succimer therapy, but the authors explicitly stated that the contribution of chelation was uncertain.

Therefore:

Succimer, DMPS, BAL, EDTA, or other chelators should not be used routinely simply because a tin concentration is elevated.

Chelation should only be considered after consultation with a medical toxicologist familiar with the exact organotin compound.


Antidote

There is no proven specific antidote for tin or organotin poisoning.

Supportive care and cessation of exposure remain the primary treatment.


Hemodialysis

There is no established role for hemodialysis as routine enhanced elimination of metallic, inorganic, or organotin compounds.

Dialysis may still be necessary for conventional indications such as:

Refractory hyperkalemia, severe renal failure, pulmonary edema, or severe acid-base disturbance

but should not be initiated solely to lower a tin concentration.


Hemoperfusion and Plasma Exchange

There is insufficient evidence to recommend routine:

Hemoperfusion

Plasma exchange

or

forced diuresis

for tin poisoning.

These approaches should be considered experimental unless needed for an unrelated established indication.


Stannosis Treatment

There is no specific drug therapy for stannosis.

Management consists of:

Termination/reduction of exposure + occupational respiratory protection + assessment of pulmonary function

Smoking cessation and evaluation for coexposures such as silica, asbestos, zinc, lead, or other welding contaminants are important because occupational exposures are frequently mixed.


Occupational Standards – Metallic and Inorganic Tin

Current NIOSH guidance gives metallic tin and most inorganic tin compounds:

NIOSH REL: 2 mg/m³ TWA as Sn

OSHA PEL: 2 mg/m³ TWA as Sn

NIOSH IDLH: 100 mg/m³ as Sn

The NIOSH/OSHA 2-mg/m³ limits exclude specific handling of tin oxides under certain regulatory tables, although NIOSH separately recommends 2 mg/m³ TWA for tin(II) and tin(IV) oxides.


Occupational Standards – Organotin Compounds

Organotins have substantially stricter limits:

NIOSH REL: 0.1 mg/m³ TWA as Sn, with skin notation

OSHA PEL: 0.1 mg/m³ TWA as Sn

NIOSH IDLH: 25 mg/m³ as Sn

The older chapter’s single 2 mg/m³ workplace limit therefore applies to metallic/inorganic tin—not to organotin compounds.

This is an important modernization.


Pregnancy

There is no single pregnancy risk category applicable to “tin,” and the former FDA letter-category framework is not appropriate for environmental or occupational tin exposure.

Animal data demonstrate developmental and endocrine effects from several organotin compounds, but human pregnancy data are limited.

The practical approach is:

Prevent significant occupational organotin exposure during pregnancy and treat clinically important poisoning according to maternal indications.

Maternal respiratory failure, severe neurotoxicity, seizures, corrosive injury, and shock should be treated without delay.


Breastfeeding

Human data on transfer of industrial organotin compounds into breast milk are sparse.

After substantial systemic organotin poisoning, breastfeeding should be discussed with occupational/environmental toxicology and pediatric specialists until the specific compound, exposure magnitude, and maternal clearance are understood.

Minor contact with ordinary consumer products containing regulated tin compounds is not equivalent to occupational organotin poisoning.


Observation

Observation depends entirely on the chemical form and route.

A trivial ingestion of a noncorrosive low-toxicity inorganic product in an asymptomatic patient may require little or no prolonged monitoring after poison-center assessment.

In contrast, patients with:

Corrosive exposure

Respiratory symptoms

Significant organotin exposure

Neurologic symptoms

Metabolic abnormalities

require prolonged evaluation.

The old blanket 4–6 hour discharge rule is therefore not appropriate for all tin compounds.


Admission

Hospital admission is appropriate for:

Caustic GI injury, respiratory symptoms after significant inhalation, persistent vomiting, major electrolyte abnormalities, altered mental status, ataxia, seizures, significant organotin exposure, or evolving organ dysfunction.


ICU Admission

ICU-level care is warranted for:

Respiratory failure, severe encephalopathy, recurrent seizures, profound hypokalemia, major metabolic acidosis, hemodynamic instability, cerebral edema, or severe caustic injury.


Prognosis – Inorganic Tin

Most minor metallic or inorganic tin exposures have an excellent prognosis.

GI irritation generally resolves with supportive care.

Chronic tin-oxide exposure may produce radiographically prominent stannosis, but it is generally a nonfibrotic pneumoconiosis rather than a progressive fibrotic lung disease.


Prognosis – Organotin

Prognosis after serious organotin poisoning is much more variable.

Some occupational clusters have shown nearly complete recovery after cessation of exposure and intensive supportive treatment.

However, severe trimethyltin poisoning has caused:

Death + persistent memory impairment + psychiatric abnormalities + seizures + long-term neurologic disability.

Therefore:

Organotin poisoning should not be described as uniformly reversible.


Important Pitfalls

The first major pitfall is treating all tin compounds as equivalent.

Metallic tin, tin oxide, tin chloride, and trimethyltin have very different toxicology.


Another major pitfall is stating that inorganic tin is completely nontoxic.

Most forms have low systemic toxicity, but soluble inorganic salts can cause GI irritation, and some concentrated compounds can be corrosive.


Do not dismiss severe neurologic symptoms after organotin exposure.

Trimethyltin can cause major limbic/cerebellar encephalopathy, seizures, hearing loss, and persistent neuropsychiatric injury.


Do not assume symptoms must begin immediately.

Organotin encephalopathy can evolve over days after exposure.


Do not rely on the historical urinary “normal tin” concentration as a universal reference range.

Total tin and organotin species are not interchangeable measurements.

Use laboratory-specific interpretation and, when possible, organotin speciation.


Do not automatically attribute welding-related fever to tin.

Classic metal fume fever is most strongly linked to zinc oxide, while tin oxide is much better established as a cause of stannosis.


Do not induce vomiting after a tin ingestion.

Routine ipecac is obsolete, particularly after corrosive exposures.


Do not perform routine gastric lavage or chemical neutralization after corrosive tin ingestion.


Do not give activated charcoal reflexively.

Charcoal is inappropriate for a primary caustic injury and generally has poor utility for metals.


Do not use chelation merely because a blood or urine tin concentration is elevated.

Succimer has been reported, but its clinical benefit in organotin poisoning remains unproven.


Finally, the occupational limits must be separated:

Metallic/inorganic tin: 2 mg/m³ TWA

Organic tin: 0.1 mg/m³ TWA

The old single 2-mg/m³ standard substantially understates the precautions required for organotin exposure.


High-Yield Toxicology Pearls

Tin toxicology depends on the compound—not simply the element.


Think:

Metallic/inorganic tin → relatively low systemic toxicity

Tin oxide inhalation → stannosis

Reactive tin compounds → corrosive/irritant injury

Organotins → systemic neurotoxicity


Stannous fluoride remains a current FDA-recognized anticaries ingredient in toothpaste; ordinary regulated dental exposure should not be confused with industrial tin poisoning.


Chronic tin-oxide inhalation causes:

Stannosis — a classically nonfibrotic pneumoconiosis


The most clinically important severe organotin is trimethyltin.

Its classic syndrome includes:

Amnesia + behavioral disturbance + hearing loss + nystagmus/ataxia + seizures ± neuropathy


Severe organotin poisoning may additionally produce:

Hypokalemia + metabolic acidosis + hyperammonemia + liver injury + leukoencephalopathy


Organotin neurotoxicity can be delayed, and persistent seizures, cognitive impairment, or behavioral dysfunction can remain long after exposure.


Blood or urine tin can support exposure, but:

There is no universal toxic concentration.

Whenever possible, distinguish total tin from organotin speciation.


For caustic tin compounds:

No emesis + no neutralization + no routine lavage + no routine charcoal

Airway assessment and modern caustic-injury evaluation take priority.


For systemic organotin poisoning:

Remove exposure + supportive care + correct K⁺/acid-base abnormalities + treat seizures + ventilate if required


There is:

No proven specific antidote.

Chelation with succimer or another chelator is not established routine therapy; reported improvement after succimer cannot be confidently attributed to the chelator.


Routine hemodialysis, hemoperfusion, and plasma exchange are not established methods of tin elimination.


Current occupational limits are:

Metallic/inorganic tin: NIOSH/OSHA 2 mg/m³ TWA; NIOSH IDLH 100 mg/m³

Organic tin: NIOSH/OSHA 0.1 mg/m³ TWA; NIOSH skin notation; IDLH 25 mg/m³


The single most important clinical warning is:

“Tin exposure” is not a diagnosis—before predicting toxicity, determine whether the patient encountered inert tin, corrosive tin, or neurotoxic organotin.



Image description
0 Comments